Showing results (1-10 of 96) with videos related to

Sort By:
Pageof 10
Current Urology Reports|April 25, 2006
The role of primary chemotherapy for prostate cancer: has the time come?P Paula Hruska, Joel Picus
American Journal of Clinical Oncology|June 1, 2005
Evaluating risk factors for the development of ifosfamide encephalopathyKevin A David, Joel Picus
Cancer|February 22, 2002
Severe interstitial pneumonitis associated with docetaxel administrationWilliam L Read, Joanne E Mortimer, Joel Picus
Journal of Hematology & Oncology|June 16, 2011
Evolving diagnostic and treatment strategies for pancreatic neuroendocrine tumorsMatthew H Kulke, Johanna Bendell, Larry Kvols, et al.
Investigational New Drugs|February 11, 2010
A phase 1, multicenter, open-label study of the safety of two dose levels of a human monoclonal antibody to human α(v) integrins, intetumumab, in combination with docetaxel and prednisone in patients with castrate-resistant metastatic prostate cancerFranklin M Chu, Joel Picus, Paula M Fracasso, et al.
Dermatology Online Journal|August 21, 2020
Pemphigus foliaceus in a patient with gastrointestinal stromal tumor treated with adjuvant imatinib mesylateHal A Lewis, David Y Chen, Ilana S Rosman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 24, 2012
Randomized, double-blind, placebo-controlled, phase III cross-over study evaluating the oral neurokinin-1 antagonist aprepitant in combination with a 5HT3 receptor antagonist and dexamethasone in patients with germ cell tumors receiving 5-day cisplatin combination chemotherapy regimens: a hoosier oncology group studyCostantine Albany, Mary J Brames, Christopher Fausel, et al.
Seminars in Oncology|February 11, 2003
Early results from a phase I/II radiation dose-escalation study with concurrent amifostine and infusional 5-fluorouracil chemotherapy for preoperative treatment of unresectable or locally recurrent rectal carcinomaRobert Myerson, Imran Zobeiri, Elisa Birnbaum, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|July 29, 2010
Gemcitabine with carboplatin for advanced biliary tract cancers: a phase II single institution studyKerry J Williams, Joel Picus, Kim Trinkhaus, et al.
Clinical Genitourinary Cancer|May 30, 2006
Prognostic significance of plasma scatter factor/hepatocyte growth factor levels in patients with metastatic hormone- refractory prostate cancer: results from cancer and leukemia group B 150005/9480Peter A Humphrey, Susan Halabi, Joel Picus, et al.
Pageof 10